These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6695150)

  • 1. Evidence that fibrin(ogen) degradation products (FDP) are adequately quantified in citrated plasma defibrinated at low pH.
    Godal HC; Hamborg T
    Scand J Haematol; 1984 Jan; 32(1):46-8. PubMed ID: 6695150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen/fibrin degradation products (FDP/fdp). Characterization, anticoagulant activity, and influence on laboratory assays.
    Arnesen H
    J Oslo City Hosp; 1977 Jun; 27(6):69-80. PubMed ID: 142131
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal antibody-based plasma assays for fibrin(ogen) and derivatives, and their clinical relevance.
    Kroneman H; Nieuwenhuizen W; Knot EA
    Blood Coagul Fibrinolysis; 1990; 1(1):91-111. PubMed ID: 2102791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of kits for the detection of fibrin(ogen) degradation products in dogs.
    Stokol T; Brooks M; Erb H; Mauldin GE
    J Vet Intern Med; 1999; 13(5):478-84. PubMed ID: 10499733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.
    Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG
    J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cross-linked fibrin polymer and degradation products by plasmin (XDP)].
    Kawai Y
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():618-22. PubMed ID: 15658405
    [No Abstract]   [Full Text] [Related]  

  • 7. New strategies in the determination of fibrin and fibrin(ogen) derivatives by monoclonal antibodies.
    Nieuwenhuizen W
    Blut; 1988 Nov; 57(5):285-91. PubMed ID: 3058234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of fibrin-fibrinogenolysis on the determination of the fibrinogen content and fibrin-fibrinogen degradation products (FDP) by means of the fibrin polymerization time (FPT test)].
    Vorlová Z; Dyr IE
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):967-70. PubMed ID: 94893
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of streptokinase on fibrinogen and related proteins in plasma.
    Bowie LJ; Kinney R; Vye M; Eckert B; Kwaan HC
    Clin Chem; 1986 Jan; 32(1 Pt 1):67-70. PubMed ID: 3940737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
    Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
    Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
    Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of fibrin generation alterations in dogs with haemangiosarcoma using resonance thrombography.
    Mischke R; Wohlsein P; Schoon HA
    Thromb Res; 2005; 115(3):229-38. PubMed ID: 15617746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation.
    Lane DA; Preston FE; VanRoss ME; Kakkar VV
    Br J Haematol; 1978 Dec; 40(4):609-15. PubMed ID: 365218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibrin x fibrinogen degradation products (FDP)].
    Mori Y; Wada H
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():604-7. PubMed ID: 15658401
    [No Abstract]   [Full Text] [Related]  

  • 15. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads.
    Greenberg CS; Devine DV; McCrae KM
    Am J Clin Pathol; 1987 Jan; 87(1):94-100. PubMed ID: 3541576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood coagulation and coagulation tests.
    Bennett JS
    Med Clin North Am; 1984 May; 68(3):557-76. PubMed ID: 6431207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fibrin(ogen)olytic properties of cathepsin D.
    Simon DI; Ezratty AM; Loscalzo J
    Biochemistry; 1994 May; 33(21):6555-63. PubMed ID: 8204591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring plasma fibrinogen levels in patients with liver cirrhosis. The occurrence of proteolytic fibrin(ogen) degradation products and their influence on several fibrinogen assays.
    de Maat MP; Nieuwenhuizen W; Knot EA; van Buuren HR; Swart GR
    Thromb Res; 1995 May; 78(4):353-62. PubMed ID: 7631315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [FDP-D dimer and FDP-E fraction (FDP-E)].
    Amemiya N
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():608-10. PubMed ID: 15658402
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxidized fibrin(ogen) derivatives enhance the activity of tissue type plasminogen activator.
    Stief TW; Marx R; Heimburger N
    Thromb Res; 1989 Oct; 56(2):221-8. PubMed ID: 2515607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.